Premium
Utility and Safety of Prolonged Temporary Transvenous Pacing Using an Active‐Fixation Lead:
Author(s) -
DE COCK C.C.,
VAN CAMPEN C.M.C.,
IN'T VELD J.A.,
VISSER C.A.
Publication year - 2003
Publication title -
pacing and clinical electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 101
eISSN - 1540-8159
pISSN - 0147-8389
DOI - 10.1046/j.1460-9592.2003.t01-1-00175.x
Subject(s) - medicine , lead (geology) , ambulatory , transvenous pacing , fixation (population genetics) , adverse effect , surgery , cardiology , anesthesia , environmental health , geomorphology , geology , population
Transvenous temporary pacing is associated with a substantial dislocation rate reported to range from 10 to 37%. The aim of the study was to assess the safety and utility of a recently introduced 3.5 Fr temporary pacing lead using active fixation in a consecutive series of 36 patients with prolonged (≥48 hours) transvenous temporary pacing (validation group). A group of 36 patients with prolonged transvenous pacing managed with a passive‐fixation lead just prior to the introduction of the active‐fixation lead served as a control group (reference group). Pacing related adverse events included dislocation, inappropriate pacing (i.e., two‐fold or greater increase of initial pacing threshold), local infection, and thrombosis. There were no significant differences in patient characteristics or duration of pacing (5.84 ± 2.4 daysin the reference group vs5.94 ± 2.6 daysin the validation group). Acute pacing threshold was significantly higher in the validation group as compared to the reference group (1.38 ± 0.67 Vvs.0.7 ± 0.21 V, P < 0.01). The dislocation rate was significantly lower in the validation group as compared to the reference group (5.5 vs 33.3%,P < 0.001). There were 11 (31%) pacing related adverse events in the validation group versus 21 (58%) in the reference group(P < 0.01). The vast majority of patients in the validation group (75%) had ambulatory temporary pacing. Thus, transvenous temporary pacing using active fixation is safe and is associated with a low dislocation rate and a reduction in pacing related adverse events. (PACE 2003; 26:1245–1248)